Periodic presumptive treatment for women with prevalent vaginal infections: secondary analysis of data from a randomized controlled trial.
作者信息
Mochache Vernon, McClelland Raymond Scott, Balkus Jennifer E
机构信息
Department of Epidemiology, University of Washington, Seattle, WA Departments of Epidemiology, Global Health, and Medicine, University of Washington, Seattle, WA Institute of Tropical and Infectious Diseases, University of Nairobi, Nairobi, Kenya Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA Department of Global Health, University of Washington, Seattle, WA
出版信息
Sex Transm Dis. 2014 Jul;41(7):453. doi: 10.1097/OLQ.0000000000000152.
Abstract
摘要
相似文献
1
Periodic presumptive treatment for women with prevalent vaginal infections: secondary analysis of data from a randomized controlled trial.对患有常见阴道感染的女性进行定期推定治疗：一项随机对照试验数据的二次分析
Sex Transm Dis. 2014 Jul;41(7):453. doi: 10.1097/OLQ.0000000000000152.
2
CDC releases 2002 guidelines for treating STDs: Part I. Diseases characterized by vaginal discharge and PID.美国疾病控制与预防中心发布2002年性传播疾病治疗指南：第一部分。以阴道分泌物和盆腔炎为特征的疾病。
Am Fam Physician. 2002 Nov 1;66(9):1777-8.
3
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.外阴阴道炎：滴虫病、外阴阴道念珠菌病和细菌性阴道病的筛查与管理。
J Obstet Gynaecol Can. 2015 Mar;37(3):266-274. doi: 10.1016/S1701-2163(15)30316-9.
4
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.改善肯尼亚有感染1型人类免疫缺陷病毒风险的女性的阴道健康：一项随机试验的结果。
J Infect Dis. 2008 May 15;197(10):1361-8. doi: 10.1086/587490.
5
Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women.高剂量阴道用甲硝唑和咪康唑定期推定治疗预防HIV阴性女性阴道感染的随机试验
J Infect Dis. 2015 Jun 15;211(12):1875-82. doi: 10.1093/infdis/jiu818. Epub 2014 Dec 19.
6
Short-term therapy for mixed vaginal infections.混合性阴道感染的短期治疗
Int J Gynaecol Obstet. 2006 Feb;92(2):149-50. doi: 10.1016/j.ijgo.2005.10.012. Epub 2005 Dec 20.
7
European guideline for the management of vaginal discharge.欧洲阴道分泌物管理指南。
Int J STD AIDS. 2001 Oct;12 Suppl 3:73-7. doi: 10.1258/0956462011923985.
8
Establishing and sustaining a healthy vaginal environment: analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections.建立和维持健康的阴道环境：定期预防性治疗阴道感染随机试验数据分析。
J Infect Dis. 2011 Jul 15;204(2):323-6. doi: 10.1093/infdis/jir241.
9
Women & diabetes. Vaginitis. What every woman needs to know.
Diabetes Self Manag. 2002 Nov-Dec;19(6):131, 133, 136-7.
10
Vaginitis in adolescents.青少年阴道炎
Adolesc Med Clin. 2004 Jun;15(2):235-51. doi: 10.1016/j.admecli.2004.02.003.
引用本文的文献
1
Lessons from Suppressive Therapy and Periodic Presumptive Treatment for Bacterial Vaginosis.细菌性阴道病抑制性治疗和定期推定治疗的经验教训。
Curr Infect Dis Rep. 2019 Aug 31;21(10):34. doi: 10.1007/s11908-019-0688-3.
本文引用的文献
1
The global epidemiology of bacterial vaginosis: a systematic review.细菌性阴道病的全球流行病学：系统评价。
Am J Obstet Gynecol. 2013 Dec;209(6):505-23. doi: 10.1016/j.ajog.2013.05.006. Epub 2013 May 6.
2
Prevalence and incidence of Trichomonas vaginalis infections in women participating in a clinical trial in Durban, South Africa.南非德班参加临床试验的女性阴道毛滴虫感染的患病率和发病率。
Sex Transm Infect. 2013 Sep;89(6):519-22. doi: 10.1136/sextrans-2012-050984. Epub 2013 Apr 20.
3
Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links.细菌性阴道病、淋病和衣原体感染在性传播疾病诊所就诊的女性中：对可能的因果关系的纵向分析。
Ann Epidemiol. 2012 Mar;22(3):213-20. doi: 10.1016/j.annepidem.2011.11.005. Epub 2011 Dec 20.
4
Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.细菌性阴道病的革兰氏染色评估和对淋病奈瑟菌、沙眼衣原体和毛滴虫性生殖器感染的定植抵抗力降低。
J Infect Dis. 2010 Dec 15;202(12):1907-15. doi: 10.1086/657320. Epub 2010 Nov 10.
5
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.细菌性阴道病与HIV感染：已发表研究的荟萃分析
AIDS. 2008 Jul 31;22(12):1493-501. doi: 10.1097/QAD.0b013e3283021a37.
6
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.改善肯尼亚有感染1型人类免疫缺陷病毒风险的女性的阴道健康：一项随机试验的结果。
J Infect Dis. 2008 May 15;197(10):1361-8. doi: 10.1086/587490.
7
Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.使用0.75%甲硝唑阴道凝胶进行抑制性抗菌治疗以预防复发性细菌性阴道病。
Am J Obstet Gynecol. 2006 May;194(5):1283-9. doi: 10.1016/j.ajog.2005.11.041. Epub 2006 Apr 21.
8
Prevalence and risk factors for vaginal candidiasis among women seeking primary care for genital infections in Dar es Salaam, Tanzania.坦桑尼亚达累斯萨拉姆因生殖器感染寻求初级保健的女性中阴道念珠菌病的患病率及危险因素。
East Afr Med J. 2005 Mar;82(3):138-43. doi: 10.4314/eamj.v82i3.9270.
9
Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.复发性外阴阴道念珠菌病的流行病学与发病机制
Am J Obstet Gynecol. 1985 Aug 1;152(7 Pt 2):924-35. doi: 10.1016/s0002-9378(85)80003-x.
Zotero 插件